Global Medical REIT (NYSE:XRN) Upgraded to Hold at Wall Street Zen
Global Medical REIT (NYSE:XRN) has been upgraded to a "hold" rating by Wall Street Zen and Weiss Ratings. The stock opened at $33.19, has a market cap of $439.1 million, and a negative P/E ratio. Institutional investors own 57.52% of the shares, with several firms increasing their stakes.
Global Medical REIT Inc. (NYSE:XRN) Receives Consensus Rating of "Moderate Buy" from Brokerages
Global Medical REIT Inc. (NYSE:XRN) has received a consensus "Moderate Buy" rating from six brokerages, with an average 12-month target price of $42.00. The company recently declared a monthly dividend of $0.25 per share, yielding 9.0%, and its stock opened at $33.23 on Friday, with institutional investors owning 57.52% of the company. Key financial metrics include a market cap of $439.63 million and a negative PE ratio of -36.92.
Vanguard (NASDAQ: XRN) disaggregates holdings; reports 0 shares for Chiron Real Estate
Vanguard has amended its Schedule 13G to report zero beneficially owned shares of Chiron Real Estate Inc common stock, following an internal realignment on January 12, 2026. This realignment means certain Vanguard subsidiaries and divisions will now report their holdings separately, adhering to SEC Release No. 34-39538. Vanguard no longer consolidates these holdings, and the filing indicates no voting or dispositive power over XRN shares.
Vanguard (NASDAQ: XRN) disaggregates holdings; reports 0 shares for Chiron Real Estate
Vanguard has filed an amended Schedule 13G/A, reporting zero beneficial ownership of Chiron Real Estate Inc. common stock. This change follows an internal realignment on January 12, 2026, which led certain Vanguard subsidiaries and divisions to report their holdings separately, as per SEC Release No. 34-39538. The filing, signed by Ashley Grim, Head of Global Fund Administration, indicates that Vanguard no longer holds voting or dispositive power over these securities.
Global Medical REIT (XRN) 10K Form and Latest SEC Filings 2026
This article provides an overview of Global Medical REIT's (XRN) SEC filings, highlighting why these documents are crucial for investors. It details the various types of filings, such as 10-K, 10-Q, and 8-K, explaining their significance. The piece also lists recent filings, including the latest 10-K and Form 4 insider transaction reports, up to March 2026.
Global Medical prices $50M in new preferred stock offering priced at $25.00 a share
The article states that Global Medical has priced a new preferred stock offering at $25.00 per share, aiming to raise $50 million. No further details are provided in the snippet.
Global Medical REIT Inc. 7.50% CUM PFD A declares $0.4687 dividend
Global Medical REIT Inc. (GMRE) has declared a cash dividend of $0.4687 per share for its 7.50% Series A Cumulative Redeemable Preferred Stock. This dividend is payable on April 15, 2026, to shareholders of record as of March 31, 2026. This announcement pertains specifically to its preferred stock, reflecting a regular distribution for these shares.
Precision Trading with Global Medical Reit Inc. (GMRE) Risk Zones
This article from Stock Traders Daily outlines AI-generated trading strategies for Global Medical Reit Inc. (GMRE), including dormant position trading, momentum breakout, and risk hedging strategies. It highlights the use of AI models for risk management and offers real-time signals and analysis to subscribers. The piece provides access details for institutional-grade analysis and personalized dashboards.
Global Medical REIT Rebrands as Chiron Real Estate
Global Medical REIT Inc. has announced its rebranding to Chiron Real Estate Inc., effective February 23, 2026. This change signifies a refreshed corporate identity while retaining its core business as a net-lease medical REIT and its REIT structure. The company's stock symbols on the NYSE will also be updated from "GMRE" to "XRN" for common stock and "GMRE PrA" and "GMRE PrB" to "XRN PrA" and "XRN PrB" for its Series A and B Preferred Stock, respectively.
Pacific Ridge Capital Partners LLC Reduces Position in Global Medical REIT Inc. $GMRE
Pacific Ridge Capital Partners LLC significantly reduced its stake in Global Medical REIT Inc. by 80.4% in the third quarter, selling over half a million shares. Despite this reduction, the institutional investor still holds 133,547 shares valued at approximately $4.5 million. The company currently has a "Moderate Buy" consensus rating from analysts with an average price target of $42.00, and recently announced a quarterly dividend of $0.75 per share, yielding 8.3%.
Earnings Breakdown: Chiron Real Estate Q4
Chiron Real Estate (NYSE: GMRE) announced its Q4 earnings, beating estimated EPS by 136.73% with $1.16 against an estimate of $0.49, and revenue increased by $3.22 million from the previous year. The company's management also provided guidance for FY 2026, forecasting earnings between $4.3 and $4.45 per share.
Global Medical REIT: Q4 Earnings Snapshot
Global Medical REIT (XRN) reported its Q4 earnings, showing funds from operations of $14 million, or 97 cents per share. The company posted a net loss of $7.4 million, with revenue reaching $38.4 million for the quarter. For the full year, funds from operations were $57.6 million on revenue of $148.2 million, and the company expects full-year funds from operations to be between $4.30 and $4.45 per share.
Redmond Asset Management LLC Sells 340,240 Shares of Global Medical REIT Inc. $GMRE
Redmond Asset Management LLC significantly reduced its stake in Global Medical REIT Inc. by 79.8% in the third quarter, selling over 340,000 shares and retaining 86,382 shares valued at $2.912 million. Despite mixed analyst sentiment, with an average target price of $42.00, the company maintains a "Moderate Buy" consensus rating. Global Medical REIT also declared a quarterly dividend of $0.75 per share, resulting in an annualized yield of 8.3%.
Aberdeen Group plc Sells 139,919 Shares of Global Medical REIT Inc. $GMRE
Aberdeen Group plc significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by selling 139,919 shares, now owning only 0.26% of the company. Despite substantial institutional ownership and a high dividend yield, the REIT faces a negative dividend payout ratio and mixed analyst ratings with an average "Moderate Buy" and a $42 target. Several other institutional investors, such as Strs Ohio and Invesco Ltd., increased their positions in GMRE.
State of New Jersey Common Pension Fund D Sells 523,201 Shares of Global Medical REIT Inc. $GMRE
State of New Jersey Common Pension Fund D significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by selling 523,201 shares, lowering its total holdings to 114,550 shares valued at $3.86 million. Despite this, other institutional investors have either bought new positions or increased their holdings in the company. Global Medical REIT recently announced a quarterly dividend of $0.75 per share, representing an annualized dividend of $3.00 and an 8.4% yield.
Global Medical REIT (GMRE) Expected to Announce Earnings on Wednesday
Global Medical REIT (GMRE) is expected to release its Q4 2025 earnings after market close on Wednesday, February 25, 2026. Analysts project earnings of $1.02 per share and revenue of $37.442 million. The company recently paid a quarterly dividend of $0.75, implying an 8.2% yield, and institutional investors own 57.52% of its stock.
LSV Asset Management Lowers Position in Global Medical REIT Inc. $GMRE
LSV Asset Management significantly reduced its stake in Global Medical REIT (NYSE:GMRE) by 80.7% in Q3, selling 643,801 shares and retaining 154,099 shares. Despite this, other institutional investors like Geode Capital Management and Invesco Ltd. increased their positions. Analyst consensus on GMRE is a "Moderate Buy" with a $41.50 price target, though some recent ratings have been neutral or sell.
Trading the Move, Not the Narrative: (GMRE) Edition
This article provides an analysis of Global Medical Reit Inc. (GMRE), identifying a neutral near-term sentiment while mid-term sentiment shows strength despite potential stalling. It highlights a significant risk-reward short setup and offers institutional trading strategies like position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for investors.
Strategic Realignment Under a New Banner: Global Medical REIT Rebrands to Chiron Real Estate Inc.
Global Medical REIT is undergoing a significant strategic pivot, rebranding to Chiron Real Estate Inc. and unveiling a new corporate identity and ticker symbol "XRN" on February 23, 2026. This move, coinciding with their 2025 annual report, aims to reinforce their focus on the medical net-lease sector, acquiring and managing physician practices and outpatient facilities. Investors are anticipating details on capital deployment from a recent Series B preferred stock issuance and the company's operating objectives under the new brand.
Strategic Realignment Under a New Banner: Global Medical REIT Rebrands to Chiron Real Estate Inc.
Global Medical REIT is undergoing a major strategic pivot, rebranding to Chiron Real Estate Inc., effective February 23, 2026, with a new ticker symbol "XRN" on the NYSE. The company will maintain its core focus on the medical net-lease sector, acquiring and managing physician practices and outpatient facilities. The upcoming Q4 and full-year 2025 financial results announcement on February 25, followed by an analyst call on February 26, will provide further details on their growth ambitions and capital deployment from their recent Series B preferred stock issuance.
Alps Advisors Inc. Sells 106,865 Shares of Global Medical REIT Inc. $GMRE
Alps Advisors Inc. significantly reduced its stake in Global Medical REIT (GMRE) by 80% in Q3, selling over 106,000 shares and retaining a small position. Despite this, Global Medical REIT announced a quarterly dividend of $0.75, yielding 8.2%, and maintains a "Moderate Buy" consensus rating from analysts, though individual analyst opinions are mixed. Insider transactions show CEO Mark Okey Decker, Jr. recently purchased 10,000 shares, increasing his ownership.
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast
Global Medical REIT Inc. (GMRE) announced it will release its Q4 and year-end 2025 financial results on February 25, 2026, after market close, followed by a conference call on February 26, 2026, at 9:00 a.m. Eastern Time. Coinciding with the results release, the company's previously announced name change to Chiron Real Estate Inc. will take effect, and calls will be streamed on its new website, chironre.com. GMRE currently operates as a net-lease medical REIT focused on acquiring and leasing healthcare facilities.
Penserra Capital Management LLC Sells 131,200 Shares of Global Medical REIT Inc. $GMRE
Penserra Capital Management LLC significantly reduced its stake in Global Medical REIT Inc. (GMRE) by selling 131,200 shares, decreasing its holdings by 79.3% in the third quarter. Despite this, Global Medical REIT maintains a "Moderate Buy" rating from analysts with an average price target of $41.50, and its CEO recently increased his personal ownership by purchasing additional shares. The company also declared a quarterly dividend of $0.75, representing an 8.2% annual yield.
A New Identity for Global Medical REIT: Rebranding as Chiron Real Estate
Global Medical REIT is rebranding as Chiron Real Estate Inc. to reflect a strategic shift in the evolving healthcare property sector. The company continues to prioritize shareholder returns through dividend distributions while navigating leadership changes on its board. Investors are awaiting the Q4 2025 financial results to assess the underlying business strength and the impact of the new strategic direction.
Global Medical REIT Announces Rebrand To Chiron Real Estate
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with the new ticker symbol "XRN" on the NYSE. The name change reflects a redefined strategy focusing on delivering value at the intersection of care, capital, and real estate, inspired by Chiron from Greek mythology. This rebrand will not alter the company's organizational structure, stockholder rights, or REIT qualification.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. (NYSE:GMRE) announced it will change its name to Chiron Real Estate Inc. and its ticker symbol to XRN on the NYSE, effective February 23, 2026. This rebranding is intended to align with the company's redefined strategy to deliver value at the intersection of care, capital, and real estate, inspired by Chiron from Greek mythology. The change will also affect its preferred stock ticker symbols and will coincide with the launch of its new corporate website, www.chironre.com.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. (NYSE:GMRE) announced it will rebrand as Chiron Real Estate Inc. and trade under the new ticker XRN on the NYSE, effective February 23, 2026. This change reflects a redefined strategy focusing on the intersection of care, capital, and real estate, and will not affect the company's structure or REIT qualification. The company also recently priced a $50 million preferred stock offering and is undergoing board changes with the retirements of two long-serving directors in 2026.
Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.
Global Medical REIT Inc. (NYSE: GMRE) will rebrand as Chiron Real Estate Inc., effective February 23, 2026, and its common stock will trade under the new ticker symbol "XRN" on the NYSE. The rebranding reflects a redefined strategy and a new mission to deliver value at the intersection of care, capital, and real estate, inspired by the Greek mythological figure Chiron. This change will not affect the company's organizational structure, stockholder rights, or REIT qualification.
Global Medical REIT in Bethesda rebrands as Chiron Real Estate
Global Medical REIT, based in Bethesda, is rebranding as Chiron Real Estate Inc. This change follows Mark Decker Jr. taking over as president and CEO in June, after which he spent six months redefining the firm's strategy. The company owns over 5.2 million square feet of medical properties.
Global Medical REIT Unveils Rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced it will change its name to "Chiron Real Estate Inc." and its ticker symbol to "XRN," effective February 23, 2026. This rebranding reflects a redefined strategy and a new mission to deliver value at the intersection of care, capital, and real estate. The company's preferred stock symbols will also change accordingly.
Global Medical REIT Unveils Rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with its common stock trading under the new ticker symbol "XRN" on the NYSE. This change reflects a redefined strategy and mission, and the company plans to release an investor presentation outlining its 2026 strategic objectives with its fourth-quarter earnings. The rebranding also includes changing ticker symbols for its Series A and B Preferred Stocks.
Global Medical REIT to rebrand as Chiron Real Estate, adopt XRN ticker
Global Medical REIT Inc. announced its rebranding to Chiron Real Estate Inc. and adoption of the new NYSE ticker symbol XRN, effective February 23, 2026. The new name, inspired by Greek mythology, reflects the company's refreshed mission at the intersection of care, capital, and real estate, following a strategy reevaluation. The change will not impact the company's organizational structure, stockholder rights, or REIT qualification, and an investor presentation detailing 2026 strategic objectives will accompany its fourth-quarter earnings release.
From Global Medical REIT to Chiron: a myth-inspired real estate rebrand
Global Medical REIT Inc. (NYSE: GMRE) announced its rebranding to "Chiron Real Estate Inc.," effective February 23, 2026, with its stock subsequently trading under the new ticker symbol "XRN" on the NYSE. The name "Chiron," inspired by Greek mythology, reflects the company's refreshed mission to deliver value at the intersection of care, capital, and real estate, emphasizing integrity and thought leadership. This strategic rebrand will not impact the company's organizational structure, stockholder rights, or REIT qualification for U.S. federal income tax purposes.
(GMRE) Volatility Zones as Tactical Triggers
This article analyzes Global Medical REIT Inc. (GMRE) using AI models to suggest trading strategies. It highlights a potential 10.1% downside with a strong risk-reward short setup due to weak near-term sentiment. The analysis provides long, breakout, and short strategies with specific entry, target, and stop-loss zones for different risk profiles.
Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Holdings in Global Medical REIT Inc. $GMRE
Universal Beteiligungs und Servicegesellschaft mbH significantly reduced its stake in Global Medical REIT Inc. by 80% during the third quarter, now holding 32,613 shares valued at approximately $1.10 million. Despite this, Global Medical REIT reported strong Q3 earnings, beating analyst estimates, and has a dividend yield of 8.7%. Insider buying by CEO Mark Okey Decker Jr. also increased his holdings in the company.
2025 Global Medical REIT payouts: check new tax breakdown
Global Medical REIT Inc. (GMRE) has published information regarding the federal income tax treatment of its 2025 dividends for both common and Series A preferred stock on its website. The data for common dividends paid in January, April, and July 2025 has been adjusted due to a one-for-five reverse stock split effective September 19, 2025. Stockholders are advised to review their 1099 Forms and consult tax advisors for personal tax consequences.
Strs Ohio Sells 265,120 Shares of Global Medical REIT Inc. $GMRE
Strs Ohio reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 62.2% in the third quarter, selling 265,120 shares and retaining 161,080 shares valued at $5.43 million. Other institutional investors like Invesco Ltd. and Marshall Wace LLP increased their holdings, significantly impacting the stock's institutional ownership. Global Medical REIT announced a quarterly dividend of $0.75 and reported quarterly earnings that beat consensus estimates, despite challenges reflected in its negative PE ratio and recent analyst downgrades.
Global Medical REIT director Henry Cole to step down in 2026
Global Medical REIT Inc. announced that director Henry Cole will step down at the end of his term in 2026. Cole has been an Independent Director since the company's inception, holding several leadership roles. Additionally, board member Ronald Marston will also retire in 2026, marking significant leadership changes for the company.
Henry Cole to Step Down from Global Medical REIT Board
Henry Cole has announced his decision to step down from the Board of Directors of Global Medical REIT Inc. (NYSE: GMRE) at the conclusion of his current term in 2026. He has served as an Independent Director since the company's inception, holding various key roles including Lead Independent Director and Chair of the Compensation and ESG Committees. The Board, led by Chairman Jeffrey Busch, expressed gratitude for Cole's significant contributions to the company's growth and guidance.
Global Medical REIT director Henry Cole to step down in 2026
Global Medical REIT Inc. announced that board member Henry Cole will retire at the end of his term in 2026. Cole has been an Independent Director since the company's inception, holding key roles including Lead Independent Director and Chair of the Compensation and ESG Committees. This leadership change aligns with other recent developments, such as a $50 million public offering and the upcoming retirement of another director, Ronald Marston.
Intrua Financial LLC Cuts Holdings in Global Medical REIT Inc. $GMRE
Intrua Financial LLC significantly reduced its stake in Global Medical REIT (GMRE) by 80.7% in Q3 2025, selling 39,919 shares, though insiders like CEO Mark Okey Decker Jr. have recently increased their holdings. GMRE offers an 8.3% dividend yield and analysts maintain a "Moderate Buy" consensus with a $41.50 price target. The company reported strong Q3 earnings, beating estimates, and has provided optimistic FY2025 EPS guidance.
LDR Capital Management LLC Sells 160,260 Shares of Global Medical REIT Inc. $GMRE
LDR Capital Management LLC significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 91.5% in the third quarter, leaving the firm with 14,846 shares. Despite this large sale, other institutional investors have increased their holdings, and Global Medical REIT's CEO recently bought 10,000 shares, signaling insider confidence. The company reported strong Q3 EPS and declared a quarterly dividend of $0.75 per share, yielding 8.4%.
Global Medical REIT Inc. $GMRE Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 80.3% in the third quarter, selling 53,926 shares and retaining 13,231 shares. Despite this, other institutional investors increased their holdings, and CEO Mark Okey Decker Jr. bought 10,000 shares, increasing his total ownership. Global Medical REIT currently pays a quarterly dividend of $0.75, equating to an 8.3% yield, and analysts have issued ratings ranging from "Strong Buy" to "Sell," with an average "Moderate Buy" rating.
Nisa Investment Advisors LLC Sells 28,491 Shares of Global Medical REIT Inc. $GMRE
Nisa Investment Advisors LLC significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by 83.4%, selling 28,491 shares and retaining 5,668 shares valued at $199,000. Despite this institutional selling, CEO Mark Okey Decker Jr. acquired 10,000 shares, increasing his ownership by 28.8% and signaling insider confidence. Global Medical REIT also offers an 8.3% dividend yield and has provided optimistic FY2025 EPS guidance, while analyst ratings average a "Moderate Buy" with a $41.50 price target.
OVERSEA CHINESE BANKING Corp Ltd Sells 63,657 Shares of Global Medical REIT Inc. $GMRE
OVERSEA CHINESE BANKING Corp Ltd significantly reduced its stake in Global Medical REIT Inc. (NYSE:GMRE) by selling 63,657 shares, decreasing its total holding to 15,045 shares. Meanwhile, CEO Mark Okey Decker, Jr. increased his personal stake by purchasing 10,000 shares, indicating insider confidence. The company also announced a quarterly dividend of $0.75 per share, leading to an annualized yield of 8.3%.
Global Medical REIT launches Series B preferred stock offering
Global Medical REIT has announced the launch of its Series B preferred stock offering. This move indicates the company's efforts to raise capital through preferred equity, which can provide a steady income stream for investors. The details of the offering, such as terms and quantity, would typically be outlined in the official announcement.
Global Medical REIT Inc. (NYSE:GMRE) Given Average Recommendation of "Moderate Buy" by Brokerages
Global Medical REIT Inc. (NYSE:GMRE) has received a "Moderate Buy" consensus recommendation from seven brokerages, with an average 12-month price target of $41.50. The CEO recently increased his stake in the company by purchasing 10,000 shares, and insiders collectively own 8.5% of the stock. GMRE also declared a quarterly dividend of $0.75, representing an 8.5% yield, and reported Q3 EPS of $1.12, beating estimates.
141,934 Shares in Global Medical REIT Inc. $GMRE Acquired by Peregrine Capital Management LLC
Peregrine Capital Management LLC recently acquired 141,934 shares of Global Medical REIT Inc. (NYSE:GMRE) worth approximately $4.79 million, representing a 1.06% stake in the company. Several other institutional investors also adjusted their holdings, with 57.52% of the stock now owned by hedge funds and institutions. Analysts have given GMRE an average "Moderate Buy" rating with a target price of $41.50, and the company recently declared a quarterly dividend of $0.75 per share.
Global Medical REIT Inc. $GMRE Position Trimmed by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. significantly reduced its stake in Global Medical REIT Inc. by 80% in Q3, selling over 71,000 shares. Despite this, other institutional investors have modified their positions, with some increasing their holdings. The article also highlights an insider purchase by CEO Mark Okey Decker Jr., the company's dividend yield of 8.5%, its recent earnings performance, and updated analyst ratings.
D.A. Davidson & CO. Reduces Stock Holdings in Global Medical REIT Inc. $GMRE
D.A. Davidson & Co. significantly reduced its stake in Global Medical REIT Inc. (NYSE: GMRE) by 80.5% in the third quarter of 2025. Despite this, other institutional investors increased their positions, and the company announced a quarterly dividend of $0.75 per share. The CEO also acquired additional shares, increasing insider ownership to 8.5%.
